Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.
about
Screening for nasopharyngeal cancerScreening for nasopharyngeal carcinomaCytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patientsThe synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cellsReactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidineEpstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.Epstein-Barr virus Zta upregulates matrix metalloproteinases 3 and 9 that synergistically promote cell invasion in vitro.Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups.The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cellsEpstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland EskimoesFrequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.Prevalence of Taiwan variant of Epstein-Barr virus in throat washings from patients with head and neck tumors in Taiwan.Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.Comparison of two laboratory extraction techniques for the detection of Epstein-Barr virus in the saliva of nasopharyngeal carcinoma patients.Epstein-Barr virus: more than 50 years old and still providing surprises.An immunoperoxidase assay for the detection of specific IgA antibody in Epstein-Barr virus infections.Immunology of head and neck cancers.Epstein--Barr virus nuclear antigen in a non-Hodgkin's lymphoma.Application of Epstein-Barr virus serology to the diagnosis and staging of North American patients with nasopharyngeal carcinoma.Perspective: Contribution of Epstein-Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells.Epstein-Barr virus and nasopharyngeal carcinoma
P2860
Q24187937-EF1EDCAE-796E-4ABE-8654-840AF5F8B88DQ24239852-06AFBFA1-30B7-46C2-865E-ED8E6087A885Q24800020-E4467C3D-0CAD-49B6-A38C-57FEBBCD8F4AQ28483778-8A9EC05E-79EC-4D4A-B7D9-35F0889E3533Q28537881-A5784EFC-257B-46CD-B8B2-6B078313C7E6Q34483687-3790C939-EEE9-42CB-9836-D346C2504378Q34586675-73567AF5-593C-4B1F-8045-B1C2905D8B66Q34706994-6482E264-88D4-40C5-96CD-1C9391727BCBQ35764478-3F5F4C11-BFC8-4BD1-8E09-B981395F50A7Q36047055-862467FD-FD53-44CD-AA82-7BD7064B16F0Q36412130-06304970-F5D3-4DB7-9D68-F155384CAA93Q36498181-F6F4E1D6-6F34-4876-87EE-69D521092480Q37069514-792D989A-2957-4346-B2DF-0C676DAD1B71Q37543048-9BB7BFCB-DDCB-4EC6-BE2B-374F9B0C8099Q38308731-AEFC9CC4-3DF1-44AF-9C9D-944917A94FDFQ38968588-ED73B6AA-ADFE-430F-95C8-3B54AAAB1A8DQ39527194-AA2A7EEC-C929-4D34-B3E5-BF662D835AA8Q40109770-32C3079B-9F73-4AAD-B0C9-FFDC100986BAQ45796867-2EA8D6E0-822C-423D-9EDF-49774BEAD8BEQ45798015-CC8A4E01-6405-4143-A90F-26B365944E1AQ54232271-9D7142EB-8AFA-4011-85A9-B792FF1C6D18Q56947843-6AB61984-D81E-4030-A144-8991EBB831DB
P2860
Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Nasopharyngeal carcinoma: sign ...... dy patterns following therapy.
@en
type
label
Nasopharyngeal carcinoma: sign ...... dy patterns following therapy.
@en
prefLabel
Nasopharyngeal carcinoma: sign ...... dy patterns following therapy.
@en
P2093
P356
P1476
Nasopharyngeal carcinoma: sign ...... dy patterns following therapy.
@en
P2093
P304
P356
10.1002/IJC.2910200504
P577
1977-11-01T00:00:00Z